Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

142 Press Releases
DateTitleCompany
30 Jul 15 Ligand Enters into Commercial License and Supply Agreement with Sanofi for Captisol-enabled SAR-125844 Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
25 Jul 15 Revolade® Recommended by CHMP for EU Approval to Treat Patients with Severe Aplastic Anemia, a Serious Blood Disorder Ligand Pharmaceuticals Incorporated,
Published by
PharmiWeb.com
24 Jul 15 Revolade® Recommended by CHMP for EU Approval to Treat Patients with Severe Aplastic Anemia, a Serious Blood Disorder Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
17 Jul 15 Ligand to Report Second Quarter Results on August 4th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
17 Jun 15 Ligand to Participate in Four Upcoming Investor Conferences Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
12 Jun 15 FDA Approves Promacta® for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
08 Jun 15 Ligand Announces Favorable Results From Phase 1b Trial With LGD-6972 in Type 2 Diabetes and Plans to Initiate a Phase 2 Trial Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
05 Jun 15 Ligand Announces New Time for June 7th Investor Presentation and Webcast at the American Diabetes Association 75th Scientific Sessions Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
02 Jun 15 Ligand Summarizes the Accounting Impact of the Viking Therapeutics Inc. IPO and Updates 2015 Financial Guidance Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
11 May 15 Ligand Acquires Rights to More Than 15 Fully-Funded Development Programs from Selexis SA Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
07 May 15 Ligand to Present Results of LGD-6972 Phase 1b Trial at American Diabetes Association 75th Scientific Sessions on June 7th and Host Investor Presentation Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
05 May 15 Ligand Partner Viking Therapeutics Announces Closing of Initial Public Offering Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
29 Apr 15 Ligand Partner Viking Therapeutics Announces Pricing of Initial Public Offering Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Apr 15 Ligand to Participate in Two Upcoming Investor Conferences Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Apr 15 Ligand to Report First Quarter Results on May 11th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Apr 15 Ligand Names Melanie J. Herman Interim Chief Financial Officer Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
20 Apr 15 Ligand Partner TG Therapeutics Presents Positive Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research (AACR) Annual Meeting Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
03 Mar 15 Ligand to Present at the 27th Annual Roth Conference on March 9th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
06 Feb 15 Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission Seeking Additional Indication for Revolade® Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
03 Feb 15 Ligand Signs License Agreement with Sermonix for Lasofoxifene Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
02 Feb 15 Ligand Promotes Matthew W. Foehr to President Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
28 Jan 15 Ligand to Present at BIO CEO and RBC Capital Markets Global Healthcare Conferences in February Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
27 Jan 15 Ligand to Report Fourth Quarter Results on February 9th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Jan 15 Ligand Partner Retrophin Receives Orphan Drug Designation for Sparsentan Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
19 Dec 14 Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
12 Nov 14 Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade™ (eltrombopag) Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
16 Oct 14 Ligand to Host Analyst Day on November 18th in New York City Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
08 Oct 14 Ligand Reports Third Quarter Revenues and Expected Diluted EPS Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
26 Sep 14 Ligand Earns Milestone Payment Triggered by EU Approval of Merck’s Captisol-enabled NOXAFIL® (posaconazole) Concentrate for Solution for Infusion Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Sep 14 Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals Inc. Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.